Boris Johnson warns pharmaceutical companies may cease EU investments if vaccine export ban goes ahead

‘Arbitrary’ blockades are not ‘sensible’, warns prime minister

Andrew Woodcock
Political Editor
Wednesday 24 March 2021 17:14
Comments
Boris Johnson warns against ‘long term damage’ of vaccine blockades

Boris Johnson has warned that pharmaceutical companies may cease investments in the EU if Brussels imposes a vaccine export ban.

Mr Johnson’s comment came as the UK remained locked in a stand-off with the EU over Brussels demands for “reciprocity” in imports and exports of doses.

EU leaders will decide in a virtual meeting on Thursday whether to block the delivery of supplies which the UK insists are due to be sent to Britain under contracts signed last year.

Speaking to the House of Commons Liaison Committee, Mr Johnson said that “arbitrary” blockades of vaccines were not “sensible” and warned that any country imposing them would make itself less attractive as a destination for investment by pharmaceutical firms.

“I don’t think that blockades of either vaccines or of the ingredients for vaccines are sensible,” said the prime minister.

Read more:

“I think that the long-term damage done by blockades can be can be very considerable.”

And he added: “I would just gently point out to anybody considering a blockade or interruption of supply chains that companies may look at such actions and and draw conclusions about whether or not it is sensible to make future investments in countries where arbitrary blockades are imposed.”

EU leaders are furious that as many as 10m vaccine doses produced in continental Europe have been sent by AstraZeneca to the UK, while none have been exported from Britain to Europe.

The row comes at a time when EU vaccination programmes are lagging well behind the UK, with a new third wave of infections surging on the continent.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in